Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer

Oncologist. 2020 Sep;25(9):e1421-e1422. doi: 10.1634/theoncologist.2020-0260. Epub 2020 Jul 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclin-Dependent Kinases
  • Humans
  • Male
  • Platinum* / therapeutic use
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / genetics
  • Taxoids / therapeutic use

Substances

  • Taxoids
  • Platinum
  • CDK12 protein, human
  • Cyclin-Dependent Kinases